Cargando…
Treating Advanced Hepatocellular Carcinoma with Sorafenib: A 10-Year Single Center Experience
INTRODUCTION: Sorafenib was the first therapy used for systemic treatment of unresectable hepatocellular carcinoma (HCC). Multiple prognosis factors associated with sorafenib therapy have been described. OBJECTIVES: The aim of this work was to evaluate survival and time to progression (TTP) on HCC p...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
S. Karger AG
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305257/ https://www.ncbi.nlm.nih.gov/pubmed/37387721 http://dx.doi.org/10.1159/000522572 |